Equity Insider News Commentary -- The 2026 National Defense Strategy explicitly prioritizes supercharging America's defense industrial base([1]) . Governments are aggressively repositioning critical ...

The investment will be made across the value chain, from drug discovery and clinical development to production.

This investment coincides with China’s burgeoning presence in the pharmaceutical industry, driven by an uptick in innovative medicines R&D.

AstraZeneca has announced a $15 billion investment in China through 2030 to expand medicines manufacturing and R&D.

AstraZeneca has announced plans to invest $15 billion in China to pioneer the next-generation of innovative medicines. CEO ...

January 2026 AstraZeneca plans to invest $15 billion in China through 2030 to pioneer the next-generation of innovative medicines Landmark investment will expand AstraZeneca's capabilities to discover ...

AstraZeneca today announced $15 billion investment in China through 2030 to expand medicines manufacturing and R&D. This investment will leverage the ...

AstraZeneca has announced a $15 billion investment in China through 2030 to expand research, development and manufacturing capabilities, supporting its long-term growth strategy and global pipeline in ...

Brunswick (NYSE:BC) executives struck an upbeat tone on the company’s fourth-quarter and full-year 2025 earnings call, pointing to a strengthening boat market in the second half of the year, improved ...

The Company remains FCF positive for the fiscal year, while delivering strong same-store sales growth and cementing its presence within the German medical cannabis market CALGARY, AB, Jan. 29, 2026 / ...

Onemed Pty Ltd, the parent company of CPAP Online Australia (cpaponline.com.au), today announced it has acquired CPAPSales.com.au and its ...

South Korean technology company LG Display has shifted at long last to a surplus in annual operating profit for the first time in four years. The Korean display ...